IQGAP-2: a novel interacting partner with the human colonic thiamin pyrophosphate transporter

The human colonic thiamin pyrophosphate transporter (hcTPPT) mediates the uptake of the microbiota-generated and phosphorylated form of vitamin B<sub>1</sub> (i.e., thiamin pyrophosphate) in the large intestine. Expression of hcTPPT along the absorptive tract is restricted to the large intestine, and the transporter is exclusively localized at the apical membrane domain of the polarized epithelial cells/colonocytes. Previous studies have characterized different physiological/pathophysiological aspects of the hcTPPT system, but nothing is currently known on whether the transporter has interacting partner(s) that affect its physiology/biology. We addressed this issue using a Y2H to screen a human colonic cDNA library and have identified three putative interactors, namely IQGAP-2, SNX-6, and DMXL-1. Focusing on IQGAP-2 (whose expression in human colonocytes is the highest), we found (using fluorescent microscopy imaging and coimmunoprecipitation approaches) the putative interactor to colocalize with hcTPPT and to directly interact with the transporter. Also, overexpressing IQGAP-2 in NCM460 cells and in human primary differentiated colonoid monolayers was found to lead to significant (<i>P</i> < 0.01) induction in TPP uptake, while knocking down (using gene-specific siRNAs) caused significant (<i>P</i> < 0.01 and <i>P</i> < 0.05) decrease in uptake. Furthermore, overexpressing IQGAP-2 in NCM460 cells was found to lead to a significant enhancement in hcTPPT protein stability. Finally, we found the expression of IQGAP-2 to be markedly suppressed in conditions/factors that negatively impact colonic TPP uptake. These results identify the IQGAP-2 as an interacting partner with the hcTPPT in human colonocytes and show that this interaction has physiological and biological consequences.<b>NEW & NOTEWORTHY</b> This study reports on the identification of IQGAP-2 as an interacting partner with the hcTPPT in human colonocytes and how that impacts the transporter's physiology and cell biology.

Authors

Institutions

Publication Details

Journal
American Journal of Physiology-Cell Physiology
Published
2024-10-14
DOI
https://doi.org/10.1152/ajpcell.00484.2024
Citations
1
Primary Topic
Alcoholism and Thiamine Deficiency
Type
article
Field-Weighted Citation Impact
0.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IQGAP-2: a novel interacting partner with the human colonic thiamin pyrophosphate transporter

Alaullah Sheikh, Kalidas Ramamoorthy, George Kim, Hamid M. Said et al.
1 citations
American Journal of Physiology-Cell Physiology
Alcoholism and Thiamine Deficiency
0.37
article

IQGAP-2: a novel interacting partner with the human colonic thiamin pyrophosphate transporter

Alaullah Sheikh, Kalidas Ramamoorthy, George Kim, Hamid M. Said, Subrata Sabui, James M. Flekenstein
article en
1 citations

Abstract

The human colonic thiamin pyrophosphate transporter (hcTPPT) mediates the uptake of the microbiota-generated and phosphorylated form of vitamin B<sub>1</sub> (i.e., thiamin pyrophosphate) in the large intestine. Expression of hcTPPT along the absorptive tract is restricted to the large intestine, and the transporter is exclusively localized at the apical membrane domain of the polarized epithelial cells/colonocytes. Previous studies have characterized different physiological/pathophysiological aspects of the hcTPPT system, but nothing is currently known on whether the transporter has interacting partner(s) that affect its physiology/biology. We addressed this issue using a Y2H to screen a human colonic cDNA library and have identified three putative interactors, namely IQGAP-2, SNX-6, and DMXL-1. Focusing on IQGAP-2 (whose expression in human colonocytes is the highest), we found (using fluorescent microscopy imaging and coimmunoprecipitation approaches) the putative interactor to colocalize with hcTPPT and to directly interact with the transporter. Also, overexpressing IQGAP-2 in NCM460 cells and in human primary differentiated colonoid monolayers was found to lead to significant (<i>P</i> < 0.01) induction in TPP uptake, while knocking down (using gene-specific siRNAs) caused significant (<i>P</i> < 0.01 and <i>P</i> < 0.05) decrease in uptake. Furthermore, overexpressing IQGAP-2 in NCM460 cells was found to lead to a significant enhancement in hcTPPT protein stability. Finally, we found the expression of IQGAP-2 to be markedly suppressed in conditions/factors that negatively impact colonic TPP uptake. These results identify the IQGAP-2 as an interacting partner with the hcTPPT in human colonocytes and show that this interaction has physiological and biological consequences.<b>NEW & NOTEWORTHY</b> This study reports on the identification of IQGAP-2 as an interacting partner with the hcTPPT in human colonocytes and how that impacts the transporter's physiology and cell biology.

American Journal of Physiology-Cell PhysiologyVol. 327(6)
University of California, Irvine (US), Washington University in St. Louis (US), Veterans Health Administration (US), Tibor Rubin VA Medical Center (US)
U.S. Department of Veterans Affairs, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Openalex Percentile: Top 35%
Alcoholism and Thiamine Deficiency
0.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.